Old Web
English
Sign In
Acemap
>
authorDetail
>
Aimee M. Burr
Aimee M. Burr
Pfizer
Osteoarthritis
Tanezumab
Medicine
Clinical trial
Placebo
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.
2021
Surgical technology international
Michael A. Mont
John A. Carrino
Mary Anne Nemeth
Aimee M. Burr
Takaharu Yamabe
Lars Viktrup
Mark T. Brown
Christine R. West
Kenneth M. Verburg
Show All
Source
Cite
Save
Citations (0)
Postoperative outcome of patients who underwent total joint replacement during the tanezumab phase 3 osteoarthritis development program: a 24-week observational study
2020
Osteoarthritis and Cartilage
M.A. Mont
J. A. Carrino
F Shafiei
Mary Anne Nemeth
Aimee M. Burr
Takaharu Yamabe
Lars Viktrup
Christine R. West
Mark T. Brown
Kenneth M. Verburg
Show All
Source
Cite
Save
Citations (0)
Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatment
2014
Journal of the Neurological Sciences
Mark T. Brown
David N. Herrmann
Mark Goldstein
Aimee M. Burr
Michael D. Smith
Christine R. West
Kenneth M. Verburg
Peter James Dyck
Show All
Source
Cite
Save
Citations (29)
1